BioNTech SE (BNTX) Short-term Investments (2018 - 2025)
BioNTech SE (BNTX) posted Short-term Investments of $8.4 billion for Q4 2025, up 61.7% on a QoQ basis from $5.2 billion in Q3 2025, and up 11.73% year-over-year from $7.5 billion in Q4 2024.
BioNTech SE (BNTX) has 8 years of Short-term Investments data on file, last reported at $8.4 billion in Q4 2025.
- In Q4 2025, Short-term Investments rose 11.73% year-over-year to $8.4 billion; the TTM figure through Dec 2025 stood at $8.4 billion (up 11.73% YoY), while the FY2025 annual figure was $8.1 billion, up 8.44% from the prior year.
- Short-term Investments climbed to $8.4 billion in Q4 2025, from $5.2 billion in the prior quarter.
- Across five years, Short-term Investments topped out at $8.4 billion in Q4 2025 and bottomed at $603118.1 in Q1 2021.
- A 5-year average of $3.5 billion and a median of $3.3 billion in 2023 frame the typical range for Short-term Investments.
- Annual changes were most pronounced in 2022 — Short-term Investments sank 55.73% — and 2023, when it surged 27727.46%.
- Year by year, Short-term Investments stood at $436.5 million in 2021, then sank by 55.73% to $193.2 million in 2022, then surged by 2620.16% to $5.3 billion in 2023, then soared by 42.75% to $7.5 billion in 2024, then advanced by 11.73% to $8.4 billion in 2025.
- The last three Short-term Investments figures came in at $8.4 billion (Q4 2025), $5.2 billion (Q3 2025), and $4.3 billion (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | BioNTech SE | 27.66 Bn | 7.53 Bn | 668.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 8.38 Bn |
| Sep 30, 2025 | 5.18 Bn |
| Jun 30, 2025 | 4.26 Bn |
| Mar 31, 2025 | 4.13 Bn |
| Dec 31, 2024 | 7.50 Bn |
| Sep 30, 2024 | 7.78 Bn |
| Jun 30, 2024 | 7.45 Bn |
| Mar 31, 2024 | 7.27 Bn |
| Dec 31, 2023 | 5.26 Bn |
| Sep 30, 2023 | 2.45 Bn |
| Jun 30, 2023 | 1.51 Bn |
| Mar 31, 2023 | 554.70 Mn |
| Dec 31, 2022 | 193.23 Mn |
| Sep 30, 2022 | 53.24 Mn |
| Jun 30, 2022 | 5.44 Mn |
| Mar 31, 2022 | 54.32 Mn |
| Dec 31, 2021 | 436.54 Mn |
| Mar 31, 2021 | 603,118.06 |
| Dec 31, 2020 | 163.58 Mn |
| Dec 31, 2019 | 1.86 Mn |
| Sep 30, 2019 | 396,131.89 |
| Dec 31, 2018 | 383,509.20 |